A sample identified as ''Warbex pour-on,'' expected to contain 13.2% famphur, and bovine tissue samples from 2 heifers that died after exhibiting signs of organophosphate intoxication were analyzed by gas chromatography/mass spectrometry (GC/MS). A product formulation problem was suspected because brain cholinesterase activities were depressed in both animals. Electron impact (EI) GC/MS of the pour-on revealed 9.7% famphur and an unidentified peak with approximately 76% of the peak area of the famphur. The unidentified peak showed a molecular ion at m/z 313, with a single Cl isotope cluster. Methane chemical ionization (MeCI) MS confirmed the molecular weight at 313 (1 Cl). A search on the molecular formula C 9 H 17 N 3 O 3 PSCl yielded a single match, isazophos. EI and MeCI GC/MS of reference isazophos confirmed the identity of the suspect peak. The concentration of isazophos in the pour-on was determined to be 6.0%. Famphur and isazophos were identified by their EI spectra and GC retention times in extracts of liver and brain from the 2 deceased animals. A GC/MS procedure utilizing selected ion monitoring (SIM) was developed for quantification of isazophos in liver, kidney, muscle, and fat of additional affected animals sacrificed at various times after exposure. Isazophos remained in animal tissues for as long as 94 days after topical exposure. Isazophos was present in fetal liver 70 days after exposure of the dam. High levels (6-3,500 ppm) of isazophos and famphur remained on the skin at 39 days postexposure.
Three incidents of organophosphate (OP) intoxication in cattle occurred in central Nebraska, within 50 miles of each other, during the second week of November 1995. All 3 herds had been poured with a famphur polur-on for cattle. Early reported clinical signs included profuse salivation, respiratory distress, and diarrhea. Central nervous system signs included ataxia and apprehension. After 12 hours, bloating occurred with severe depression, the animals refused to eat, and death occurred. One abortion was reported in 1 of the herds, 2 in another, and none in the third. Several animals had stained hair coats from the pour-on application. The stain remained visible for over 120 days.
Treatment included atropine sulfate (0.6-1.0 mg/kg) as needed, charcoal, and washing of the animals. Of the 240 animals exposed, 35 died and morbidity varied among the herds. All herds had used the same famphur pour-on lot number. Clinical signs and response to atropine suggested cholinesterase inhibitor toxicosis. Brain cholinesterase activities were determined 5 and were reduced in 5 of 6 brains submitted from the 3 herds.
A sample of the suspect pour-on was submitted to the laboratory to confirm label specifications that indicated the active ingredient to be famphur at 13.2%. Necropsies were subsequently conducted in 2 herds at 27, 29, 38, 39 , and 94 days postexposure for withdrawal time data. Tissue samples were collected from 3 animals per herd and from fetuses of the sacrificed pregnant females. This report describes the identification and confirmation of isazophos, an OP insecticide approved for use on turf and some crops but not on animals, in the pour-on expected to contain famphur as the active ingredient. The report further describes the identification of isazophos in tissues of 8 heifers and a fetus and the subsequent development of methodology to quantify residues of the isazophos in exposed animals. Data are presented on the length of time necessary for the disappearance of isazophos from tissues and skin of exposed animals. Cases of animal poisonings due to mistaken addition of insecticides to animal feed are too numerous to cite. However, this case of product misformulation of an insecticide intended for food animal use is apparently a rare occurrence, and no previous literature report of such an error could be found.
Materials and methods
Chemicals and equipment. Organic solvents were U.V. grade, a and 18 meg-ohm, organic-free water was obtained from a 4-bowl water purification system. b The internal stan-dard spiking solution consisted of 20 ug/ml diphenylamine c in CH 2 Cl 2 . Reference standard famphur and isazophos were obtained from a commercial source. d The gas chromatograph/mass spectrometry (GC/MS) system utilized for 70-eV electron impact (EI) MS consisted of an autosampler e interfaced to a GC and mass selective detector (MSD). f The GC column was a 30-m ϫ 0.25-mm I.D. ϫ 0.25-m (film) DB-5MS. g The system utilized for positive ion methane chemical ionization MS (MeCI/GC/MS) consisted of a TSQ-70 triple-stage quadrupole mass spectrometer h fitted with a 15 m ϫ 0.25 mm I.D. ϫ 0.25 m (film) DB-5MS capillary column. g Gel permeation chromatography was carried out on a gel permeation chromatograph i with a 2.5 ϫ 18-cm column of styrene divinylbenzene packing (20 g in cyclohexane/ CH 2 Cl 2 , 1:1). i Qualitative GC/MS screen. Twenty grams of rumen contents, liver, or brain from cattle exhibiting neurological signs or aborted fetuses was extracted and purified by modification of the GC/MS extraction routinely used for clinical cases. 8 Briefly, samples were homogenized with 1 ml diphenylamine (20 g/ml in CH 2 Cl 2 ) and 300 ml acetonitrile in a blender. The mixture was suction filtered with a fast filter paper k and transferred to a 1-liter separatory funnel together with 10 ml saturated NaCl solution and 600 ml deionized water. The solution was extracted twice with 100 ml each CH 2 Cl 2 , adjusted to pH Ͼ9 with boric acid buffer (25 g boric acid/liter, adjusted to pH 11 with approximately 30 g NaOH), and extracted twice more with 100 ml each CH 2 Cl 2 . The 4 CH 2 Cl 2 fractions were combined by filtering through anhydrous Na 2 SO 4 into a round-bottom flask and reduced to 5 ml on a rotary evaporator. One-half the sample was evaporated to dryness at 38 C with a stream of N 2 , dissolved in 5 ml cyclohexane/CH 2 Cl 2 (1:1), and purified by gel permeation chromatography (GPC). i The GPC fraction eluting between 165 ml and 490 ml was evaporated to near dryness on a rotary evaporator, transferred to an autosampler vial, evaporated to dryness, and dissolved in 0.1 ml cyclohexane/ CH 2 Cl 2 (1:1). The sample was analyzed on the MSD with a 4-mm I.D. split liner with cup packed with silane treated glass wool and split ratio of 10:1. The chromatograph was temperature programmed as follows. The initial GC oven temperature was 80 C. After a 0.5-min hold, temperature was ramped at 17 C/min to 180 C, held for 1 min, ramped at 10 C/min to 250 C, held 2 min, then finally ramped at 20 C/min to 320 C to remove slowly eluting contaminants.
GC/MS analysis of pour-on. The suspect sample of famphur pour-on was diluted 1:200 in CH 2 Cl 2 and 1 l was injected directly on to the MSD (injector split 10:1) under full scan (40-600 amu) conditions. Famphur and isazophos in the suspect pour-on were quantified in samples diluted 1: 500 and 1:1,000 by comparison with standard curves of mass (ng) versus total ion current intensity (peak area). MeCI/GC/MS confirmed the identity of isazophos in the suspect pour-on. CI conditions were as follows: CH 4 pressure, 9800 mtorr; source, 150 C; manifold, 70 C; electron energy, 70 eV; electron current, 300 A. The GC was temperature programmed from 80 to 300 C over a 28-min span, with He flow at 1.6 cm 3 /min.
Quantification of isazophos in tissues. Frozen samples of liver, kidney, muscle, and skin were allowed to thaw, and 20-g aliquots were extracted by blending with 250 ml CH 3 CN. Control samples (20 g) were placed in 250 ml CH 3 CN, spiked with 0, 0.010, and 0.100 ppm isazophos, and blended as above. The CH 3 CN was filtered and mixed with 600 ml H 2 O and 10 ml saturated NaCl, and isazophos was partitioned into CH 2 Cl 2 under neutral and basic conditions. The CH 2 Cl 2 was evaporated to dryness, and the sample was dissolved in 1:1 cyclohexane/methylene chloride. Skin samples were analyzed directly for isazophos and famphur by GC/MS. Liver, kidney, and muscle samples were purified by GPC (see above) after optimization of the GPC collection time for maximum isazophos recovery. Isazophos was found in the fraction collected between 135 and 325 ml. The GPC fraction containing isazophos was evaporated just to dryness and dissolved in 500 l of CH 2 Cl 2 for GC/MS analysis with selected ion monitoring (SIM).
Fat samples (2 g) and control fat spiked with 0, 0.100, 0.200, and 1.00 ppm isazophos were extracted by a modified procedure for chlorinated pesticide residues. 4, 7 Samples were coarsely minced and transferred to an 8-oz. glass mortar. Samples were ground until homogenous with 100 g anhydrous sodium sulfate. The mixture was transferred to a 2.5cm ϫ 30-cm glass column fitted with a coarse glass frit and containing about 2.5 cm of anhydrous sodium sulfate on the bottom. The sample mixture was eluted into a 600-ml beaker with 400 ml of 1:1 (v/v) ether/petroleum ether at a flow rate of 3-5 ml/min after an initial equilibration period of 10 min. The ether/petroleum ether was allowed to evaporate in a fume hood overnight and then quantitatively transferred to a 15-ml conical graduated centrifuge tube with 1:1 (v/v) cyclohexane/CH 2 Cl 2 prior to cleanup by GPC. The GPC fraction containing isazophos was evaporated just to dryness and dissolved in 500 l of CH 2 Cl 2 for GC/MS analysis with SIM.
GPC samples (1 l) were injected onto the MSD by the splitless mode with 2-mm-I.D. quartz deactivated splitless liner and with injector temperature optimized for isazophos at 260 C. The GC temperature program was the same as described for the qualitative GC/MS screen. Isazophos was detected by SIM of m/z 257, 259, and 285 at 100 msec/amu.
Reference standard solutions of isazophos were prepared in CH 2 Cl 2 containing 15 ppm cholesterol. d Quantification was accomplished by comparison with a standard curve, generally consisting of 5 points, 0, 0.2, 0.4, 1, and 5 ng isazophos, utilizing peak areas of the total ion current of the 3 ions monitored. Linearity of the standard curves was required to be greater than correlation coefficient (r) ϭ 0.995. Unknown peak areas were required to fall between the upper and lower points of the standard curve. Specificity was verified by observation of the relative ion intensities of m/z 257, 259, and 285 and the GC retention time of the peak in relation to reference isazophos. Solvent blanks and blank tissue samples were run before unknown tissue extracts or spikes, which were bracketed (every 4-7 samples) with a 1ng reference standard. The 1-ng standards were required to be within Ϯ22% of 1 ng for the data to be accepted.
Tissue samples from animals from 2 of the exposed herds were collected at 27, 29, 38, 39, and 94 days postexposure. Three animals were sacrificed per herd, and samples were collected from liver, kidney, fat and muscle from beneath the application site (lumbar dorsal fascia, longissimus dorsi), Figure 1 . Total ion current chromatogram (EI, 70 eV) of a 1/ 200 dilution of the suspect pour-on. The peak eluting at 15.58 minutes was identified as famphur by comparison of the retention time and mass spectrum with reference famphur. The peak at 17.1 minutes was tentatively identified as an isomer of famphur by its mass spectrum. The mass spectrum of the peak eluting at 10.34 minutes is compared with reference isazophos in Fig. 2 . fat from kidney, abdominal/peritoneal fat, and nearby muscle (semitendinosus). Liver and kidney samples were collected from fetuses from the pregnant cows. Samples were placed on ice in the field, frozen upon arrival at the Nebraska laboratories, shipped frozen in insulated containers, and stored frozen at Michigan State University until the time of analysis. Samples were extracted and purified, and isazophos was quantified by GC/MS SIM. Skin with the hair on was collected from the sacrificed animals at 38, 39, and 94 days postexposure. Isazophos and famphur were quantified by GC/MS (full scans) after purification as described under the quantification procedure.
Results
GC/MS of pour-on. EI/GC/MS analysis of the pouron revealed famphur, retention time (r.t.) 15.58 minutes, a small famphur isomer at 17.1 minutes, and an unidentified peak at r.t. 10.34 minutes with approximately 76% of the peak area of the famphur (Fig. 1) . The unidentified peak showed a molecular ion at m/z 313, with a single Cl isotope cluster (Fig. 2) . MeCI/ GC/MS confirmed the molecular weight (MW) at 313 (1 Cl). The MeCI spectrum included major ions at (MϩH) ϩ ϭ 314 (1 Cl), (MϩC 2 H 5 ) ϩ ϭ 342 (1 Cl), and (MϩC 3 H 5 ) ϩ ϭ 354 (1 Cl). A search of the EI spectrum with the on-line Wiley 138K Mass Spectral Database, Rev. B.00.00, f showed a partial match with triazophos. Triazophos has a MW of 313 but no Cl in the molecular formula. Manual searches of published spectral databases were negative. It was reasoned that replacement of the phenyl ring of triazophos with C 3 H 6 Cl would result in a compound with the same nominal MW, 313, but with the required Cl isotope cluster. The Chemical Information Systems database Structure and Nomenclature Search System k was utilized to search on the molecular formula C 9 H 17 N 3 O 3 PSCl and yielded a single match, isazophos. Reference isazophos was obtained, and GC/MS under the same conditions confirmed the identity of the suspect peak by r.t. and mass spectrum (Fig. 2) . The concentration of isazophos in the pour-on was determined to be 6.0% and the concentration of famphur, 9.7%.
GC/MS analysis of tissues. Famphur and isazophos were identified in tissue samples of dead animals by their EI spectra and GC r.t. Table 1 indicates that both brain and liver of adults and fetuses contained the OPs after exposure of 3 separate herds to the contaminated pour-on.
Quantification of isazophos in tissues. A quantitative method for determination of isazophos residues in tissues of exposed animals was developed to establish a withdrawal time for marketing purposes. Accuracy was determined by recovery from fortified samples because known incurred residue tissue samples were obviously not available. Precision was determined by replicate determinations of fortified samples. Each set of replicates was fortified, extracted, and analyzed on a different day, so the variability represents true dayto-day variability of the method. Table 2 shows the results of recovery of isazophos added to control target tissues at the range of concentrations expected in the incurred samples. The limit of quantification was set at the level of analyte that gave a signal to noise ratio of Ͼ10:1, determined experimentally to be 0.010 ppm in tissues and 0.020 ppm in fat. The limit of detection was set at 2ϫ the noise level, and that was determined experimentally to be 0.002 ppm in tissue and 0.004 ppm in fat. Table 3 contains tissue isazophos concentrations determined in adults and fetuses from 2 separate herds inadvertently treated with the contaminated pour-on. Residues were present in sacrificed adults and fetuses from the pregnant animals from days 27 through 70 ‡ Indicates several characteristic ions were identified at the correct retention time, but a complete spectrum was not obtained. postexposure to the contaminated pour-on. One animal contained trace amounts of isazophos in fat 94 days after exposure. Table 4 shows the concentrations of famphur and isazophos found in skin of treated animals from 38 to 94 days after the pour-on was applied. Figure 3 shows the November death losses in herds 1 and 2. Surviving animals of herd 2 were washed extensively by the local fire department on November 13.
Discussion
To optimize the quantitative measurement of isazophos, minor modifications were made to the extraction and cleanup procedure routinely used for GC/MS screening for unknown toxicants. Careful studies of the elution of isazophos in the 1:1 cyclohexane/CH 2 Cl 2 system indicated approximately 17% of the isazophos would be lost under our normal conditions. Moving up the collection time increased recovery but resulted in a less pure fraction for GC/MS. The resulting lipid impurities did not interfere with measurement of the isazophos peak but required more frequent cleaning of the GC/MS injector port and capillary column.
Studies comparing 10:1 split injections (usual procedure) with splitless indicated splitless was far superior. Split injections were more variable and lost a proportionately higher percentage of isazophos (i.e., the ratio of isazophos/famphur decreased significantly with split injections). The injection volume was optimized at 1 l. Two-microliter injections of isazophos did not yield consistent results in the splitless mode. In addition, the injection temperature was optimized at 260 C for isazophos, giving a cleaner injector port for extended periods. A selected ion monitoring protocol 1/141 0 0 T T 0 0 0 0 * T represents trace levels of isazophos found above the method detection limits (0.002 ppm in tissues, 0.004 ppm in fat) but below the level of quantification (0.010 ppm in tissues, 0.020 in fat).
Figure 3.
Daily death losses in animals of 2 herds exposed to the same lot number of Warbex pour-on. Herd 1 q, herd 2 Ⅵ. Herd 1 was poured on November 6. Herd 2 was poured on November 11 and washed on November 13. was set up to allow enhanced sensitivity in the detection of isazophos. Ions m/z 257, 259, and 285 were monitored at 100 milliseconds/amu. Low mass ions such as 119 and 161 were not chosen because of the greater likelihood of interference from endogenous substances, especially in the situation of trace residues in complex matrices such as liver, kidney, and skin. Ions 257 and 259 were chosen so the unique isotope ratio of the chlorine atom could be verified. Chlorine is not a common atom in biological substances; its presence indicates a xenobiotic and, in this case, helped to confirm isazophos, in the opinion of the authors. The molecular ion m/z 313 was not chosen because it represented only a small fraction of the ion current and would result in loss of sensitivity. The ion ratios, combined with the chromatographic retention time, provided the necessary selectivity to the isazophos measurement. 3 Pure reference isazophos at the low concentrations needed to create a standard curve for quantitative purposes was found to bind significantly to the glass of volumetric flasks, etc., even if glass was silanized. Ad-dition of cholesterol to the reference standard solutions prevented the loss of reference material to the glass.
The GC/MS procedure was prone to degradation by buildup of sample impurities on the injector port surfaces and capillary column, so that frequent cleaning of these areas, followed by several ''priming'' runs, was necessary.
To estimate the accuracy of the analysis, the recovery of isazophos added to control tissues at an appropriate range of concentrations was determined ( Table  2 ). This approach is acceptable in situations where tissues with known concentrations of the incurred analyte are unavailable. 3 The mean recoveries of 87% to 123% were in the range expected for analytes at ppb con-centrations. 3, 6 Within-laboratory precision (repeatability) was estimated by replicate analyses of fortified tissues ( Table 2) . This approach is also allowable during development of a method used in a crisis situation, where intralaboratory trials are precluded. 3 The repeatability values obtained in this study ( Table 2) were within or slightly above the expected ranges for analytes at the ppb level (relative standard deviation) RSD r 15-30%). 6 Initial analytical methods utilized EI/GC/MS in the full scan mode to identify the presence of both famphur and the contaminant isazophos in the brain and liver of deceased animals and an aborted fetus when deaths occurred shortly after exposure to the pour-on. This, combined with depressed brain cholinesterase, confirmed the OP toxicosis. Several factors may have contributed to the toxicity of the contaminated product even though the famphur itself was present in reduced concentration compared with label specifications (9.7% vs. 13.2%). Isazophos, an insecticide for use on turf, maize, rice, and other crops but not on animals, has a lower median lethal dose (LD 50 ) when applied to skin than does famphur. The skin-rat and skin-rabbit LD 50 s for isazophos are 118 and 755 mg/kg, respectively, 1 whereas the skin-rat and skin-rabbit LD 50 s for famphur are 400 and 1460 mg/kg, respectively. 2 Furthermore, the total amount of OPs present was greater than the label amount (6% isazophos ϩ 9.7% famphur, total 15.7% OP). Thus, replacement of approximately 25% of the famphur with close to twice the amount of a compound with 2-3ϫ greater dermal toxicity may have led to the enhanced toxicity of the pour-on.
It is evident in Tables 3 and 4 that greater concentrations of isazophos were present in tissues, aborted fetuses, and skin of herd 1 than of herd 2. Approximately 20 hours after exposure, the rural fire department had attempted to wash off the pour-on from animals of herd 2. The treatment regimen of herd 1 did not incorporate washing of the animals. Isazophos was present at up to 0.33 ppm in liver and 0.20 ppm in kidney of an animal from herd 1 70 days after exposure and at trace levels in fat of another animal 94 days after exposure. This herd also experienced the more severe clinical signs and greatest death loss (Fig.  3) . Figure 3 shows that death losses were curtailed in herd 2 after surviving animals were washed, whereas death losses were sustained for about 2½ weeks in animals of herd 1 that were not washed.
The results of this incident also point out the need for use of caution in extrapolation of pharmacokinetic data obtained under controlled study conditions to in-stances of field exposure to toxicants under uncontrolled conditions. For instance, pour-on stains were visible for at least 120 days in herd 1. These stains, along with high retention of OPs in the skin, could have been on account of xylene, which was present in the isazophos formulation and would assist in the transport of the OPs and other extraneous (dark) material into the dermal layers of the skin. The combination of the xylene carrier and dermal rather than oral exposure may have extended the time of clearance of OP residues from these animals.
